MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2022

Jun 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2022-06-16

Reporting Person: MILLIGAN DAVID V (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-16	Stock Option (Right to buy)	$65.06	A	9470	Acquired	2025-06-16	Common Stock (9470)	Direct

Footnotes

F1: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.